NCT04953013View on ClinicalTrials.gov

Risk Potential for Organ Dysfunction Associated With Sodium Bicarbonate Therapy (SBT) in Critically Ill Patients

CompletedOBSERVATIONAL

Enrollment

664

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

February 1, 2020

Study Completion Date

September 1, 2020

Conditions

Metabolic Acidosis; Critically Ill Patients; Organ Dysfunction

Interventions

DRUG

sodium bicarbonate

Drug exposure

Trial Locations (1)

100191

Critical Care Medicine Department, Beijing

All Listed Sponsors

lead

Peking University Third Hospital

OTHER

NCT04953013 - Risk Potential for Organ Dysfunction Associated With Sodium Bicarbonate Therapy (SBT) in Critically Ill Patients | Biotech Hunter | Biotech Hunter